Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales
NCT02210702 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2014-08-07
Summary
This is a prospective, randomized, controlled cohort study. This study will look at the effect of Ethinyl Estradiol 35mcg/Norethindrone 1mg and Ethinyl Estradiol 20 mcg/Norethindrone 1mg on postpartum depressive symptoms and sexual function scores when compared to a control group using no hormonal contraception. Depressive symptoms and sexual function will be measured using the Edinburgh Postnatal Depression Scale (EPDS), Arizona Sexual Experiences Scale (ASEX), and Brief Index of Sexual Functioning for Women (BISF-W). Participants will begin taking the medication at Week 3 postpartum, and these outcomes will be measured at baseline (0-1 day postpartum), Week 3, and Week 6-7. The investigators hypothesize that there will be an ethinyl estradiol dose related response in EPDS, ASEX, and BISF-W scores at Week 6-7, which would indicate a decrease in depressive symptoms and increase in sexual function in both of the oral contraceptive groups.
Conditions
- Postpartum Depressive Mood
- Postpartum Sexual Function
Interventions
- DRUG
-
Ethinyl Estradiol 35mcg/Norethindrone 1mg
- DRUG
-
Ethinyl Estradiol 20mcg/Norethindrone 1mg
Sponsors & Collaborators
-
The Jones Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2015-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
NCT00212277 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00932321 ·Status: COMPLETED ·Phase: PHASE3
-
A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women
NCT01953809 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
NCT00089414 ·Status: TERMINATED ·Phase: PHASE2
-
The Oral Contraceptive Pill for Premenstrual Worsening of Depression
NCT00633360 ·Status: COMPLETED ·Phase: NA
-
Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
NCT05294341 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of LY2216684 in Healthy Females
NCT01373931 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder
NCT00128934 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
NCT00236795 ·Status: COMPLETED ·Phase: PHASE3
-
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
NCT02957630 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant
NCT04074174 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive
NCT00196326 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
NCT00344383 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone
NCT02652650 ·Status: COMPLETED ·Phase: PHASE1
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol
NCT00307632 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol
NCT03547024 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.
NCT05505162 ·Status: COMPLETED ·Phase: PHASE1
-
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
NCT00033358 ·Status: COMPLETED ·Phase: PHASE2
-
"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
NCT06396221 ·Status: COMPLETED ·Phase: NA
-
Postpartum Family Planning
NCT03844633 ·Status: TERMINATED ·Phase: PHASE4
-
Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)
NCT00511355 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
NCT01482338 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS
NCT00161681 ·Status: COMPLETED ·Phase: PHASE3